Japan stem cell researcher says results valid

Image
AP Tokyo
Last Updated : Apr 09 2014 | 1:06 PM IST
The scientist accused of falsifying data in a widely heralded stem-cell research paper says that despite mistakes in her work the results are valid.
Haruko Obokata struggled at times to maintain her composure during a news conference today in the western city of Osaka.
She insisted she did not tamper with the data to fabricate her results, and said she does not intend to retract a report that appeared in the scientific journal Nature.
Obokata apologised repeatedly for having used the wrong images and having altered an image in a report on using a simple lab procedure to grow tissue for treating illnesses such as diabetes and Parkinson's disease.
She has contested allegations of research malpractice made by a panel of scientists at the government-funded Riken Center for Development Biology.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 09 2014 | 1:06 PM IST

Next Story